FGC
SUPN icon

Financial Gravity Companies’s Supernus Pharmaceuticals SUPN Stock Holding History

Financial Gravity Companies’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$1K Buy
+32
New +$1.38K ﹤0.01% 1224
2018
Q1 		$1K Sell
28
-845
-97% -$35.3K ﹤0.01% 1260
2017
Q4 		$34K Buy
+873
New +$34.5K 0.04% 401

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Financial Gravity Companies's SUPN Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Supernus Pharmaceuticals (SUPN) in Q4 2018: 32 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1224 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in SUPN as recently as Q1 2018.

Financial Gravity Companies first reported a position in SUPN in Q4 2017 and has held it in 3 quarters since. The position peaked at $34K in Q4 2017. 274 funds tracked by Wall St. Rank hold SUPN as of Q4 2018.

  • Financial Gravity Companies held 32 shares of Supernus Pharmaceuticals worth $1K as of Q4 2018.
  • Supernus Pharmaceuticals was a new Financial Gravity Companies position in Q4 2018.
  • Supernus Pharmaceuticals made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1224 holding.
  • Financial Gravity Companies first reported a position in Supernus Pharmaceuticals in Q4 2017 and has held it in 3 quarters since.
  • Financial Gravity Companies's Supernus Pharmaceuticals position peaked at $34K in Q4 2017.
  • 274 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.